Articles by Gregory S. Blank - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Gregory S. Blank

Gregory S. Blank


Gregory S. Blank is the director of late-stage purification at Genentech, Inc.

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies
March 2, 2009

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.

ADVERTISEMENT

ADVERTISEMENT

Click here